A closer look at the tumor subtype revealed that the triple negative receptor status had a significantly adverse impact on the brain metastasis-free survival (log rank test, p < 0.01) compared to the combined subtypes luminal A, luminal B and HER2 overexpressing. This evidence concerns the gene ERBB2 and neoplasm.